{
    "nct_id": "NCT06182579",
    "official_title": "Phase I Dose-Escalation Study of RiMO-401 With Radiation in Advanced Tumors",
    "inclusion_criteria": "* Diagnosis of advanced or metastatic cancer not amenable to curative therapy\n* Lesion that is amenable to palliative radiotherapy\n* Lesion that is technically feasible for intratumoral injection\n* Target tumor in region not in the field that was irradiated within the past six months\n* Patients with advanced or metastatic HNSCC must have progressed on or been intolerant to standard of care therapies including platinum-based chemotherapy and anti-PD(L)1 therapy, prior to study enrollment\n* Patient must have recovered from acute toxic effects (â‰¤ grade 1) of previous cancer treatments prior to enrollment\n* Has measurable disease, defined as at least 1 tumor that fulfills the criteria for a target lesion\n* ECOG score of 0-1\n* Have a life expectancy of at least 12 weeks\n* Have adequate bone marrow reserve and adequate liver function\n* Both males and females and their partners of childbearing potential must agree to use adequate contraceptive measures\n* Patients must sign a study-specific informed consent form prior to study entry\n* Age 18 years or older.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with a histological diagnosis of lymphomas and/or leukemias\n* Patients with significant blood vessels (such as carotid artery encasement) or other major structures in the tumor region to be injected\n* Patients may not have received chemotherapy, targeted therapies, immunotherapies, biologic response modifiers and/or hormonal therapy within the last 14 days\n* Ongoing clinically significant infection at or near the incident lesion\n* Major surgery over the target area (excluding placement of vascular access) <21 days from beginning of the study drug or minor surgical procedures <7 days\n* Other severe acute or chronic medical or psychiatric conditions or laboratory abnormality that would make the patient inappropriate for enrollment in this study\n* Has any mental or medical condition that prevents the patient from giving informed consent or participating in the trial\n* Pregnant and nursing women\n* Patients with a target lesion located in a previously irradiated field\n* Patients with a target lesion in the field that had complications from prior radiotherapy that are not amenable to repeat irradiation.",
    "miscellaneous_criteria": ""
}